Surrogate endpoint of progression-free (PFS) and overall survival (OS) for advanced ovarian cancer (AOC) patients (pts) treated with neo-adjuvant chemotherapy (NACT): Results of the CHIVA randomized phase II GINECO study

Affiliation auteursAffiliation ok
TitreSurrogate endpoint of progression-free (PFS) and overall survival (OS) for advanced ovarian cancer (AOC) patients (pts) treated with neo-adjuvant chemotherapy (NACT): Results of the CHIVA randomized phase II GINECO study
Type de publicationJournal Article
Year of Publication2019
AuteursLecuru F., Pujade-Lauraine E., Hamizi S., Caumont-Prim A., Raban N., Malaurie E., Pautier P., Kaminsky-Forrett M-C., Meunier J., Alexandre J., Berton-Rigaud D., Dohollou N., Dubot C., Floquet A., Favier L., Venat-Bouvet L., Fabbro M., Louvet C., Lortholary A., Ferron G.
JournalANNALS OF ONCOLOGY
Volume30
Pagination415
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0923-7534